Super-precise CRISPR Tool Enters US Clinical Trials for the First Time

Base editing, which makes specific changes to a cell’s genome, is put to the test in CAR-T-cell treatments for leukemia. The first participant had been treated using immune cells with four base-edited genes, equipping the cells to better target and destroy tumors.